论文信息 - Pro108Ser mutant of SARS-CoV-2 3CLpro reduces the enzymatic activity and ameliorates COVID-19 severity in Japan - 字舞流文

Pro108Ser mutant of SARS-CoV-2 3CLpro reduces the enzymatic activity and ameliorates COVID-19 severity in Japan

M. Suematsu | H. Saya | K. Kosaki | T. Takenouchi | K. Fukunaga | T. Maruno | H. Siomi | M. Ishii | M. Amagai | H. Ishizu | Y. Iwasaki | M. Murata | Y. Kabe | M. Noda | S. Uchiyama | Y. Uwamino | S. Uno | N. Hasegawa | Y. Kitagawa | K. Abe